Growth Metrics

Fennec Pharmaceuticals (FENC) Accounts Payables (2010 - 2025)

Fennec Pharmaceuticals posted quarterly Accounts Payables of $4.6 million for Q4 2025, up 43.01% year-on-year from $3.2 million in Q4 2024, and down 20.99% on a QoQ basis from $5.9 million in Q3 2025.

Fennec Pharmaceuticals (FENC) has 16 years of Accounts Payables data on file, last reported at $4.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 43.01% year-over-year to $4.6 million; the trailing twelve-month figure through Dec 2025 stood at $4.6 million (up 43.01% YoY), and the FY2025 full-year result was $4.6 million, up 43.01% from the prior year.
  • Accounts Payables for Q4 2025 stood at $4.6 million, down from $5.9 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $5.9 million in Q2 2025 and bottomed at $677000.0 in Q2 2021.
  • The 5-year median for Accounts Payables is $3.0 million (2023), against an average of $3.2 million.
  • The widest annual swing landed in 2021, when Accounts Payables slumped 75.43%; it then surged 207.59% in 2022.
  • A 5-year view of Accounts Payables shows it stood at $777000.0 in 2021, then soared by 207.59% to $2.4 million in 2022, then soared by 58.08% to $3.8 million in 2023, then fell by 14.21% to $3.2 million in 2024, then surged by 43.01% to $4.6 million in 2025.
  • The last three Accounts Payables figures came in at $4.6 million (Q4 2025), $5.9 million (Q3 2025), and $5.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.05 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 10.62 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 8.64 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 489.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.03 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 126.63 Mn
10 Fennec Pharmaceuticals 281.48 Mn 244.70 Mn 7.67 Mn 4.64 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 4.64 Mn
Sep 30, 2025 5.87 Mn
Jun 30, 2025 5.94 Mn
Mar 31, 2025 5.28 Mn
Dec 31, 2024 3.24 Mn
Sep 30, 2024 3.87 Mn
Jun 30, 2024 4.45 Mn
Mar 31, 2024 5.20 Mn
Dec 31, 2023 3.78 Mn
Sep 30, 2023 2.94 Mn
Jun 30, 2023 3.01 Mn
Mar 31, 2023 2.95 Mn
Dec 31, 2022 2.39 Mn
Sep 30, 2022 2.53 Mn
Jun 30, 2022 1.74 Mn
Mar 31, 2022 1.22 Mn
Dec 31, 2021 777,000.00
Sep 30, 2021 1.15 Mn
Jun 30, 2021 677,000.00
Mar 31, 2021 2.51 Mn
Dec 31, 2020 1.57 Mn
Sep 30, 2020 2.68 Mn
Jun 30, 2020 2.76 Mn
Mar 31, 2020 1.68 Mn
Dec 31, 2019 1.61 Mn
Sep 30, 2019 788,000.00
Jun 30, 2019 1.23 Mn
Mar 31, 2019 1.30 Mn
Dec 31, 2018 1.03 Mn
Sep 30, 2018 1.87 Mn
Jun 30, 2018 709,000.00
Mar 31, 2018 1.03 Mn
Dec 31, 2017 855,000.00
Sep 30, 2017 492,000.00
Jun 30, 2017 296,000.00
Mar 31, 2017 224,000.00
Dec 31, 2016 244,000.00
Sep 30, 2016 235,000.00
Jun 30, 2016 345,000.00
Mar 31, 2016 225,000.00
Dec 31, 2015 297,000.00
Sep 30, 2015 252,000.00
Jun 30, 2015 401,000.00
Mar 31, 2015 384,000.00
Dec 31, 2014 308,000.00
Sep 30, 2014 364,000.00
Jun 30, 2014 335,000.00
Mar 31, 2014 154,000.00
Dec 31, 2013 212,000.00
Sep 30, 2013 315,000.00
Jun 30, 2013 716,000.00
Mar 31, 2013 698,000.00
Dec 31, 2012 259,000.00
Sep 30, 2012 315,000.00
Jun 30, 2012 276,000.00
Mar 31, 2012 374,000.00
Dec 31, 2011 342,000.00
Sep 30, 2011 414,000.00
Jun 30, 2011 239,000.00
Dec 31, 2010 272,000.00